Q5H (p.Gln5His) variant of SGCD (Delta-sarcoglycan)

Q5H (p.Gln5His) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes structural context.

Q5H (p.Gln5His) variant details